Certified by Founder Lodge
Polaris Partners
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $30,000,000
33 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Exceptional entrepreneurs. Remarkable bonds. Extraordinary companies.
Since 1996, Polaris has been guided by the fundamental beliefs that people come first and true partnerships make all t
| Company | Date | Round | Raised |
|---|---|---|---|
 Volastra Therapeutics |
March, 08 ,2023 | Series A | $60,000,000 |
 FOLX Health |
October, 17 ,2022 | Series B | $30,000,000 |
 Crossbow Therapeutics, Inc |
July, 12 ,2023 | Series A | $80,000,000 |
 Neumora |
October, 17 ,2022 | Series B | $112,000,000 |
 Tausight |
August, 16 ,2023 | Unknown | $6,000,000 |
 CAMP4 Therapeutics |
July, 20 ,2022 | Series B | $100,000,000 |
 Triveni Bio |
October, 27 ,2023 | Series A | $92,000,000 |
 °Nomad Health |
June, 27 ,2022 | Unknown | $105,000,000 |
 Engine Biosciences |
November, 01 ,2023 | Series A | $27,000,000 |
 Faro Health Inc. |
February, 16 ,2023 | Unknown | $20,000,000 |
 BeMe Health |
November, 15 ,2023 | Unknown | $1,500,000 |
| Volastra Therapeutics |
March, 08 ,2023 | Series A | $60,000,000 |
 Seismic Therapeutic |
December, 05 ,2023 | Series B | $121,000,000 |
| Crossbow Therapeutics, Inc |
July, 12 ,2023 | Series A | $80,000,000 |
 Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
| Tausight |
August, 16 ,2023 | Unknown | $6,000,000 |
| Triveni Bio |
October, 27 ,2023 | Series A | $92,000,000 |
 Cohere Health |
February, 06 ,2024 | Unknown | $50,000,000 |
| Engine Biosciences |
November, 01 ,2023 | Series A | $27,000,000 |
 Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| BeMe Health |
November, 15 ,2023 | Unknown | $1,500,000 |
 Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
| Seismic Therapeutic |
December, 05 ,2023 | Series B | $121,000,000 |
 Livara Health |
May, 03 ,2024 | Series B | $15,000,000 |
| Tome Biosciences |
December, 14 ,2023 | Series B | $213,000,000 |
 ByHeart |
May, 14 ,2024 | Unknown | $95,000,000 |
| Cohere Health |
February, 06 ,2024 | Unknown | $50,000,000 |
 TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
| Matter Neuroscience |
March, 01 ,2024 | Unknown | $26,000,000 |
| Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
| Livara Health |
May, 03 ,2024 | Series B | $15,000,000 |
| ByHeart |
May, 14 ,2024 | Unknown | $95,000,000 |
| TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
